Correlation Between Amylyx Pharmaceuticals and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Eliem Therapeutics, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Eliem Therapeutics.
Diversification Opportunities for Amylyx Pharmaceuticals and Eliem Therapeutics
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Amylyx and Eliem is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Eliem Therapeutics
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 1.16 times more return on investment than Eliem Therapeutics. However, Amylyx Pharmaceuticals is 1.16 times more volatile than Eliem Therapeutics. It trades about 0.29 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 216.00 in Amylyx Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 338.00 from holding Amylyx Pharmaceuticals or generate 156.48% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Amylyx Pharmaceuticals vs. Eliem Therapeutics
Performance |
Timeline |
Amylyx Pharmaceuticals |
Eliem Therapeutics |
Amylyx Pharmaceuticals and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amylyx Pharmaceuticals and Eliem Therapeutics
The main advantage of trading using opposite Amylyx Pharmaceuticals and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |